MK-8527

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for MK-8527, covering 2020-09-28 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009) [Phase 1]